Prominent Industry Leaders in the Vietnam Allopurinol Market | Competitive Landscape 2026

Prominent Industry Leaders in the Vietnam Allopurinol Market

Vietnam Allopurinol Market is influenced by a combination of local pharmaceutical companies, each making an impact on the growth of the market through their robust R&D, manufacturing strengths, and focus on affordable generics. Major players of this market include DHG Pharmaceutical Joint Stock Company, Pymepharco Joint Stock Company, and Imexpharm Corporation.

Vietnam Allopurinol Market Overview

According to 6Wresearch, the market for Allopurinol in Vietnam is anticipated to grow, driven by an increase in the incidence of gout and hyperuricemia, along with an increase in the awareness of the benefits of allopurinol as a treatment. Allopurinol is a treatment for high levels of uric acid, and is a major treatment for gout and kidney stones.

The market is driven by the growing elderly population, improved accessibility of healthcare, and the rising occurrence of chronic diseases. Furthermore, the increase in healthcare expenditure, as well as the government’s support for the drug industry is expected to be beneficial for the market’s growth.

Competitive Landscape

The competitive landscape of the Vietnam Allopurinol industry is dominated by drug manufacturers with a strong market presence, as well as local companies that offer cost-effective products. The market players have managed to establish themselves in the market with the help of partnerships, quality products, and R&D for new forms of allopurinol. These companies also aim to capture the increasing demand for cost-effective treatment options in Vietnam, particularly as patients shift from traditional herbal remedies to Western urate-lowering therapies.

Below is a list of leading players operating in the Vietnam Allopurinol Market:

1. DHG Pharmaceutical Joint Stock Company

DHG Pharma is providing a wide range of essential medicines and maintaining a dominant market share in the gout treatment segment.

2. Pymepharco Joint Stock Company

Pymepharco produces high-quality Allopurinol in EU-GMP standard facilities.

3. Imexpharm Corporation

Imexpharm is known for its high standard of manufacturing excellence, focusing on the production of generic cardiovascular and metabolic disease treatments.

4. Domesco Medical Import-Export JSC

Domesco is a significant player in the domestic market, offering various strengths of Allopurinol for chronic gout management.

5. Mekophar Chemical Pharmaceutical JSC

Mekophar utilizes its extensive manufacturing history to provide affordable Allopurinol formulations to the hospital and retail sectors.

6. Cuu Long Pharmaceutical JSC (Pharimexco)

This company is a major manufacturer of essential drugs and empty capsules, supporting the broader metabolic treatment market.

7. Traphaco Joint Stock Company

Traphaco is a pioneer in "Green" pharmaceuticals, integrating traditional strengths with modern chemical-pharmaceutical production.

8. Vidipha Central Pharmaceutical JSC

Vidipha produces a vast portfolio of generic drugs, including anti-inflammatory and urate-lowering therapies used in long-term patient care.

9. OPC Pharmaceutical Joint Stock Company

OPC is a prestigious name, focusing on modernizing traditional medicine and producing high-standard pharmaceutical products.

10. Stada Vietnam J.V. Co., Ltd.

A joint venture that has brought international quality standards to the local market, offering specialized generic solutions for metabolic disorders.

Prominent Industry Leaders in the Vietnam Allopurinol Market: FAQs